Was conducted this 96-week international study of more than 130 locations in 30 countries, vs. 8 percentmpare the antiretroviral efficacy and safety of once-daily atazanavir reinforced twice daily increased lopinavir . Both treatments simultaneously. Ritonavir, each in combination with fixed-dose tenofovir and emtricitabine as background therapy.
Pivotal data show efficacy in the treatment of of darusentan resistant hypertension in The Lancet DAR-311 Results – Baseline demographics Baseline demographic and clinical characteristics were similar between treatment groups. The mean age of the patients was 62 years old. There were almost an equal number of women and men in the study and 20 % of patients were black. The mean body mass index was 32 kg/m2, an indication of obesity. Forty % of patients were diabetic and 25 % of patients had chronic kidney disease . At baseline, 58 % of patients on four or more antihypertensive medications. The mean baseline trough sitting SBP and DBP measures were 151 mm Hg and 86 mm Hg or.Boston Scientific announced positive results from a substudy of patients left principal coronary heart illness that by dealt of the TAXUS Express2 paclitaxel – eluting Coronary systems. SYNTAX – LE MANS is an substudy of the pioneering SYNTAX trial, is the first randomized controlled clinical study of percutaneous coronary intervention with the Taxus stent for coronary artery bypass surgery of patients with left main disease and / or to compare a significant restriction all the three coronary arteries . Which sub-study from A. By A. Pieter Kappetein, on the annual EuroPCR Scientific Program in Barcelona.